HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation in the industry through its best-in-class CESS® nanonization

SAN FRANCISCO, Nov. 6, 2019 /PRNewswire/ -- Today, Cricket Health, a comprehensive kidney care provider, published a white paper, "Machine Learning for Chronic Kidney Disease Detection & Risk Stratification," announcing its proprietary machine learning model to identify patients at-risk for or living with chronic kidney disease (CKD). Designed by Cricket

LEEDS, England, Nov. 6, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a clinical-stage pharmaceutical company leading the development of Live Biotherapeutics, today announced preliminary safety and clinical observations from an ongoing Phase I/II clinical trial, in collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ

HONG KONG and SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Ping An Insurance (Group) of Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx: 2318; SSE: 601318) is proud to represent the financial technology sector as a partner of UNLEASH 2019, the global innovation lab for sustainable development, in

OSLO, Nov. 6, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces today that the primary endpoint of Overall Response Rate (ORR) has been met in Cohort A of its Phase II clinical trial (BGBC008) evaluating bemcentinib, its first in class sel

Medical business to drive future growth of Olympus Corporation as a global medtech leader A thorough transformation plan implemented to drive the change from within and ensure goals are achieved As a result >20% operating profit margin is targeted at the fiscal year March 2023 TOKYO, Nov. 6, 2019

PACIFIC PALISADES, Calif., Nov. 6, 2019 /PRNewswire/ -- The regular conference will be on Saturday and Sunday May 16 - 17, 2020 and the Clinician's Conference is Friday May 15, 2020.

IRVINE, Calif., Nov. 6, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE Mark to expand use of the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients diagnosed with aortic stenosis who a

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- P-MEC China, co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets, will take place at the Shanghai New International Expo Center (SNIEC) from June 22-24, 2020. The event will be co-located with CP

SAN FRANCISCO, Nov. 5, 2019 /PRNewswire/ -- Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors who have suffered significant losses to submit their loss now to le